Perspective Therapeutics, Inc. 8-K

What Happened
Perspective Therapeutics, Inc. (CATX) filed a Current Report on Form 8-K on April 1, 2026, to disclose an updated corporate presentation. The presentation is filed as Exhibit 99.1 and is incorporated by reference into the report. The filing was signed by Joel Sendek, Chief Financial Officer.

Key Details

• Filing date: April 1, 2026.
• Document filed: Corporate Presentation (Exhibit 99.1) incorporated by reference.
• Report type: Form 8-K, Item 8.01 (Other Events) and Item 9.01 (Exhibits).
• Filing signed by Joel Sendek, CFO; cover page interactive XBRL file (Exhibit 104) is included.

Why It Matters
This 8-K notifies investors that Perspective updated its investor-facing materials; the presentation may contain refreshed strategic, program or corporate overview information. The filing does not disclose earnings, revenue figures, executive changes, mergers, or other material financial results — it is an update to company communications rather than a report of quarterly results or personnel actions. Investors who follow CATX may want to review Exhibit 99.1 for any new disclosures or messaging about business priorities.